[Skip to Content]
[Skip to Content Landing]
August 23/30, 2000

Preparticipation Cardiovascular Screening for Young Athletes

Author Affiliations

Stephen J.LurieMD, PhD, Contributing EditorIndividualAuthorPhil B.FontanarosaMD, Executive Deputy EditorIndividualAuthor

JAMA. 2000;284(8):957-958. doi:10.1001/jama.284.8.956

To the Editor: In their discussion of preparticipation cardiovascular screening for detecting potentially lethal cardiovascular diseases in college-aged athletes, Dr Pfister and colleagues1 made no mention of mitral valve prolapse, which is the most frequent valve disorder in the United States2 and not an uncommon cause of sudden cardiac death.3 Mitral valve prolapse is responsible for 2% of cases of sudden cardiac death in young competitive athletes, the same percentage as coronary artery disease.4 In the report of the 26th Bethesda Conference,5 a special section was devoted to mitral valve prolapse along with hypertrophic cardiomyopathy and other diseases.6 The recommendations were as follows:

First Page Preview View Large
First page PDF preview
First page PDF preview